In summary, this investigation demonstrates a novel mechanism for cancer protection, inhibition of AC5, which is unique not only because this has not been described previously, but also because parallel studies with a pharmacological inhibitor also supports a protective role for inhibiting AC5. The gene discussed is ADCY5; the disease is cancer.